CBD can be used safely in women with advanced breast cancer and clinical anxiety

This Phase II trial explores CBD for anxiety in breast cancer patients, indicating safety and potential anxiolytic effects despite no primary outcome success.

Biomea’s stock bounces back as FDA lifts clinical hold on diabetes trials

Biomea’s BMF-219 is an investigational irreversible covalent inhibitor of menin. Image credit: eamesBot / Shutterstock. Biomea Fusion’s stock is on the up after the company

September 27, 2024

Study links acid-reducing drugs to increased risk of migraine

People who take acid-reducing drugs may have a higher risk of migraine and other severe headache than people who do not take these medications, according

April 25, 2024

Largest COVID Vax Safety Study; Kratom Deaths Rising; Gov. Threatens Hospital Chain

Note that some links may require registration or subscription. An analysis based on 99 million people globally who received COVID-19 vaccines confirmed previously established safety

February 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.